Cargando…
Incidence and risk factors for capecitabine-induced symptomatic cardiotoxicity: a retrospective study of 452 consecutive patients with metastatic breast cancer
OBJECTIVES: Case reports of capecitabine cardiotoxicity resemble those seen with intravenous 5-fluorouracil (5-FU) with chest pain as the predominant manifestation, but few studies of capecitabine cardiotoxicity are available. We aimed to determine the incidence of symptomatic cardiotoxicity from ca...
Autores principales: | Polk, Anne, Shahmarvand, Nahid, Vistisen, Kirsten, Vaage-Nilsen, Merete, Larsen, Finn Ole, Schou, Morten, Nielsen, Dorte Lisbeth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5073470/ https://www.ncbi.nlm.nih.gov/pubmed/27798021 http://dx.doi.org/10.1136/bmjopen-2016-012798 |
Ejemplares similares
-
A systematic review of the pathophysiology of 5-fluorouracil-induced cardiotoxicity
por: Polk, Anne, et al.
Publicado: (2014) -
Capecitabine-induced cardiotoxicity: case report and review of the literature
por: Ang, C., et al.
Publicado: (2010) -
Cardiotoxicity of 5-fluorouracil and capecitabine in Chinese patients: a prospective study
por: Peng, Jianjun, et al.
Publicado: (2018) -
Mass, D. 452 Deutsche Messe /
por: Schubert, Franz, 1797-1828
Publicado: (1996) -
Capecitabine-induced cardiotoxicity: more evidence or clinical approaches to protect the patients’ heart?
por: Fontanella, Caterina, et al.
Publicado: (2014)